MedTrace Logo

Study of A Long Lasting Local Anesthestic for Hand, Wrist or Finger Surgery

NCT02058303 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare Exparel, a new, long-lasting numbing medication and a shorter-acting nerve block to a traditional single-shot nerve block in patients having hand, wrist or finger surgery.

Conditions

  • Hand Injuries
  • Wrist Injuries
  • Finger Injuries

Interventions

DRUG

Exparel Forearm block

20-30 mL Mepivacaine will be used for the supraclavicular block following the forearm block.

DRUG

Bupivacaine supraclavicular block

20-30mL 0.5% bupivacaine

Sponsors & Collaborators

  • Pacira Pharmaceuticals, Inc

    collaborator INDUSTRY

  • Jose Soberon, MD

    lead OTHER

Principal Investigators

  • Jose Soberon, MD · Ochsner Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02058303 on ClinicalTrials.gov